Systematic identification of the HSP90 candidate regulated proteome

Molecular and Cellular Proteomics

Volumn 11, Issue 6, 2012, Pages

  Wu, Zhixiang ^a   Gholami, Amin Moghaddas ^a   Kuster, Bernhard ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Munich Center for Integrated Protein Science   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; PROTEIN; PROTEIN AXL; PROTEIN BIRC6; PROTEIN DDR1; PROTEIN FLII; PROTEIN ISG15; PROTEIN KINASE; PROTEIN TRIO; PROTEOME; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; BENZOQUINONE DERIVATIVE; MACROCYCLIC LACTAM; PU H71; PURINE DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; ISOTOPE LABELING; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEOMICS; DRUG ANTAGONISM; HALF LIFE TIME; KINETICS; METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BENZODIOXOLES; BENZOQUINONES; CELL LINE, TUMOR; HALF-LIFE; HSP90 HEAT-SHOCK PROTEINS; HUMANS; KINETICS; LACTAMS, MACROCYCLIC; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; PROTEIN KINASES; PROTEIN STABILITY; PROTEOME; PURINES; SIGNAL TRANSDUCTION;

EID: 84862323158     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.016675     Document Type: Article

References (52)

1. Taipale, M., Jarosz, D. F., and Lindquist, S. (2010) HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat. Rev. Mol. Cell Biol. 11, 515-528
2. Trepel, J., Mollapour, M., Giaccone, G., and Neckers, L. (2010) Targeting the dynamic HSP90 complex in cancer. Nat. Rev. Cancer 10, 537-549
3. Picard, D. HSP90 interactors. http://www.picard.ch/downloads/ Hsp90interactors.pdf.
4. Zhao, R., and Houry, W. A. (2007) Molecular interaction network of the Hsp90 chaperone system. Adv. Exp. Med. Biol. 594, 27-36
5. Whitesell, L., and Lindquist, S. L. (2005) HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 5, 761-772
6. Hao, H., Naomoto, Y., Bao, X., Watanabe, N., Sakurama, K., Noma, K., Motoki, T., Tomono, Y., Fukazawa, T., Shirakawa, Y., Yamatsuji, T., Matsuoka, J., and Takaoka, M. (2010) HSP90 and its inhibitors. Oncol. Rep. 23, 1483-1492
7. Zou, J., Guo, Y., Guettouche, T., Smith, D. F., and Voellmy, R. (1998) Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell 94, 471-480
8. Kim, H. R., Kang, H. S., and Kim, H. D. (1999) Geldanamycin induces heat shock protein expression through activation of HSF1 in K562 erythroleukemic cells. IUBMB Life 48, 429-433
9. Gray, P. J., Jr., Prince, T., Cheng, J., Stevenson, M. A., and Calderwood, S. K. (2008) Targeting the oncogene and kinome chaperone CDC37. Nat. Rev. Cancer 8, 491-495
10. Bohonowych, J. E., Gopal, U., and Isaacs, J. S. (2010) Hsp90 as a gate-keeper of tumor angiogenesis: clinical promise and potential pitfalls. J. Oncol. 2010, 412985
11. Hartson, S. D., and Matts, R. L. (2011) Approaches for defining the Hsp90-dependent proteome. Biochim. Biophys. Acta. 1823, 656-667
12. Tsaytler, P. A., Krijgsveld, J., Goerdayal, S. S., Rüdiger, S., and Egmond, M. R. (2009) Novel Hsp90 partners discovered using complementary proteomic approaches. Cell Stress Chaperones 14, 629-638
13. Sharma, K., Vabulas, R. M., Macek, B., Pinkert, S., Cox, J., Mann, M., and Hartl, F. U. (2011) Quantitative proteomics reveals that Hsp90 inhibition preferentially targets kinases and the DNA damage response. Mol. Cell. Proteomics 11, M111.014654
14. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
15. Schirle, M., Heurtier, M. A., and Kuster, B. (2003) Profiling core proteomes of human cell lines by one-dimensional PAGE and liquid chromatography-tandem mass spectrometry. Mol. Cell. Proteomics 2, 1297-1305
16. Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., Reader, V., Sweetman, G., Bauer, A., Bouwmeester, T., Hopf, C., Kruse, U., Neubauer, G., Ramsden, N., Rick, J., Kuster, B., and Drewes, G. (2007) Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol. 25, 1035-1044
17. Bantscheff, M., Schirle, M., Sweetman, G., Rick, J., and Kuster, B. (2007) Quantitative mass spectrometry in proteomics: a critical review. Anal. Bioanal. Chem. 389, 1017-1031
18. Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., and Selbach, M. (2011) Global quantification of mammalian gene expression control. Nature 473, 337-342
19. Schwanhäusser, B., Gossen, M., Dittmar, G., and Selbach, M. (2009) Global analysis of cellular protein translation by pulsed SILAC. Proteomics 9, 205-209
20. Immormino, R. M., Kang, Y., Chiosis, G., and Gewirth, D. T. (2006) Structural and quantum chemical studies of 8-aryl-sulfanyl adenine class Hsp90 inhibitors. J. Med. Chem. 49, 4953-4960
21. Lemeer, S., Bluwstein, A., Wu, Z., Leberfinger, J., Muller, K., Kramer, K., and Kuster, B. (2011) Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1. J. Proteomics
22. Wu, Z., Doondeea, J. B., Gholami, A. M., Janning, M. C., Lemeer, S., Kramer, K., Eccles, S. A., Gollin, S. M., Grenman, R., Walch, A., Feller, S. M., and Kuster, B. (2011) Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer. Mol. Cell. Proteomics 10, M111.011635
23. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372
24. Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., and Mann, M. (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794-1805
25. Team, R. D. C. (2011) R: A language and environment for statistical computing. R Foundation for Statistical Computing,. Vienna, Austria., ISBN 3-900051-07-0, URL 〈http://www.R-project.org/〉.
26. Huber, W., von Heydebreck, A., Sültmann, H., Poustka, A., and Vingron, M. (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 Suppl 1, S96-104
27. Wu, Z., Doondeea, J. B., Moghaddas Gholami, A., Janning, M. C., Lemeer, S., Kramer, K., Eccles, S. A., Gollin, S. M., Grenman, R., Walch, A., Feller, S. M., and Kuster, B. (2011) Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer. Mol. Cell. Proteomics
28. Karp, N. A., Huber, W., Sadowski, P. G., Charles, P. D., Hester, S. V., and Lilley, K. S. (2010) Addressing accuracy and precision issues in iTRAQ quantitation. Mol. Cell. Proteomics 9, 1885-1897
29. Smyth, G. K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3
30. Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., Hornik, K., Hothorn, T., Huber, W., Iacus, S., Irizarry, R., Leisch, F., Li, C., Maechler, M., Rossini, A. J., Sawitzki, G., Smith, C., Smyth, G., Tierney, L., Yang, J. Y., and Zhang, J. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80
31. Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289-300
32. Huang da, W., Sherman, B. T., Tan, Q., Kir, J., Liu, D., Bryant, D., Guo, Y., Stephens, R., Baseler, M. W., Lane, H. C., and Lempicki, R. A. (2007) DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 35, W169-175
33. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
34. Supek, F., Bošnjak, M., Škunca, N., and Šmuc, T. (2011) REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One 6, e21800
35. Ruepp, A., Brauner, B., Dunger-Kaltenbach, I., Frishman, G., Montrone, C., Stransky, M., Waegele, B., Schmidt, T., Doudieu, O. N., Stümpflen, V., and Mewes, H. W. (2008) CORUM: the comprehensive resource of mammalian protein complexes. Nucleic Acids Res. 36, D646-650
36. Magné, N., Fischel, J. L., Dubreuil, A., Formento, P., Poupon, M. F., Laurent-Puig, P., and Milano, G. (2002) Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 ("Iressa"). Br. J. Cancer 86, 1518-1523
37. Linger, R. M., Keating, A. K., Earp, H. S., and Graham, D. K. (2010) Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors. Expert Opin. Ther. Targets 14, 1073-1090
38. Price, J. T., Quinn, J. M., Sims, N. A., Vieusseux, J., Waldeck, K., Docherty, S. E., Myers, D., Nakamura, A., Waltham, M. C., Gillespie, M. T., and Thompson, E. W. (2005) The heat shock protein 90 inhibitor, 17-allylamino-17- demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. Cancer Res. 65, 4929-4938
39. Guo, F., Rocha, K., Bali, P., Pranpat, M., Fiskus, W., Boyapalle, S., Kumaraswamy, S., Balasis, M., Greedy, B., Armitage, E. S., Lawrence, N., and Bhalla, K. (2005) Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Cancer Res. 65, 10536-10544
40. Kim, H. R., Lee, C. H., Choi, Y. H., Kang, H. S., and Kim, H. D. (1999) Geldanamycin induces cell cycle arrest in K562 erythroleukemic cells. IUBMB Life 48, 425-428
41. Jiang, S., Katayama, H., Wang, J., Li, S. A., Hong, Y., Radvanyi, L., Li, J. J., and Sen, S. (2010) Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells. Horm. Cancer 1, 11-20
42. Shinozaki, F., Minami, M., Chiba, T., Suzuki, M., Yoshimatsu, K., Ichikawa, Y., Terasawa, K., Emori, Y., Matsumoto, K., Kurosaki, T., Nakai, A., Tanaka, K., and Minami, Y. (2006) Depletion of hsp90beta induces multiple defects in B cell receptor signaling. J. Biol. Chem. 281, 16361-16369
43. Yorgin, P. D., Hartson, S. D., Fellah, A. M., Scroggins, B. T., Huang, W., Katsanis, E., Couchman, J. M., Matts, R. L., and Whitesell, L. (2000) Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases. J. Immunol. 164, 2915-2923
44. Moulick, K., Ahn, J. H., Zong, H., Rodina, A., Cerchietti, L., Gomes DaGama, E. M., Caldas-Lopes, E., Beebe, K., Perna, F., Hatzi, K., Vu, L. P., Zhao, X., Zatorska, D., Taldone, T., Smith-Jones, P., Alpaugh, M., Gross, S. S., Pillarsetty, N., Ku, T., Lewis, J. S., Larson, S. M., Levine, R., Erdjument-Bromage, H., Guzman, M. L., Nimer, S. D., Melnick, A., Neckers, L., and Chiosis, G. (2011) Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nat. Chem. Biol. 7, 818-826
45. Shimamura, T., and Shapiro, G. I. (2008) Heat shock protein 90 inhibition in lung cancer. J. Thorac. Oncol. 3, S152-159
46. Tauchi, T., Okabe, S., Ashihara, E., Kimura, S., Maekawa, T., and Ohyashiki, K. (2011) Combined effects of novel heat shock protein 90 inhibitor NVP-AUY922 and nilotinib in a random mutagenesis screen. Oncogene 30, 2789-2797
47. LaBonte, M. J., Wilson, P. M., Fazzone, W., Russell, J., Louie, S. G., El-Khoueiry, A., Lenz, H. J., and Ladner, R. D. (2011) The dual EGFR/HER2 inhibitor lapatinib synergistically enhances the antitumor activity of the histone deacetylase inhibitor panobinostat in colorectal cancer models. Cancer Res. 71, 3635-3648
48. Takayama, S., Xie, Z., and Reed, J. C. (1999) An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J. Biol. Chem. 274, 781-786
49. Wang, D., Li, Y., and Shen, B. (2002) A novel erythroid differentiation related gene EDRF1 upregulating globin gene expression in HEL cells. Chin. Med. J. 115, 1701-1705
50. Sakurai, T., Kondoh, N., Arai, M., Hamada, J., Yamada, T., Kihara-Negishi, F., Izawa, T., Ohno, H., Yamamoto, M., and Oikawa, T. (2007) Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy. Cancer Sci. 98, 1775-1784
51. Hauser, H. P., Bardroff, M., Pyrowolakis, G., and Jentsch, S. (1998) A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. J. Cell Biol. 141, 1415-1422
52. Van Houdt, W. J., Emmink, B. L., Pham, T. V., Piersma, S. R., Verheem, A., Vries, R. G., Fratantoni, S. A., Pronk, A., Clevers, H., Borel Rinkes, I. H., Jimenez, C. R., and Kranenburg, O. (2011) Comparative Proteomics of Colon Cancer Stem Cells and Differentiated Tumor Cells Identifies BIRC6 as a Potential Therapeutic Target. Mol. Cell. Proteomics 10, M111.011353